diazoxide has been researched along with Water-Electrolyte Imbalance in 3 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Water-Electrolyte Imbalance: Disturbances in the body's WATER-ELECTROLYTE BALANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3 to 18 years of age, with severe hypertension associated with the hemolytic uremic syndrome, periarteritis, and renal transplant rejection received minoxidil, an antihypertensive agent, for three to 36 weeks." | 9.04 | Minoxidil therapy in children with severe hypertension. ( Bernstein, BH; Ettenger, RB; Fine, RN; Hanson, V; Malekzadeh, MH; Pennisi, AJ; Singsen, BH; Takahashi, M; Uittenbogaart, C, 1977) |
| "The present study sought to determine whether chemical destruction of peripheral catecholaminergic fibers with 6-hydroxydopamine (6OHDA) attenuates vasopressin (VP) and oxytocin (OT) secretion stimulated by hemorrhage, hypotension, and hyperosmolality." | 7.73 | Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. ( Lone, U; Madden, CJ; Stocker, SD; Sved, AF; Wilson, ME, 2006) |
| "Diazoxide is a non-diuretic benzothiadiazine derivative, one of a group of substances introduced into clinical practice in the 1950s for the treatment of hypertension." | 5.43 | Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. ( Inoue, Y; Komatsu, Y; Miyoshi, H; Nakamura, A; Tajima, K; Takano, T; Takihata, M; Terauchi, Y; Tsuchiya, H; Yahagi, S; Yamakawa, T; Yoshida, M, 2016) |
| "3 to 18 years of age, with severe hypertension associated with the hemolytic uremic syndrome, periarteritis, and renal transplant rejection received minoxidil, an antihypertensive agent, for three to 36 weeks." | 5.04 | Minoxidil therapy in children with severe hypertension. ( Bernstein, BH; Ettenger, RB; Fine, RN; Hanson, V; Malekzadeh, MH; Pennisi, AJ; Singsen, BH; Takahashi, M; Uittenbogaart, C, 1977) |
| "The present study sought to determine whether chemical destruction of peripheral catecholaminergic fibers with 6-hydroxydopamine (6OHDA) attenuates vasopressin (VP) and oxytocin (OT) secretion stimulated by hemorrhage, hypotension, and hyperosmolality." | 3.73 | Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats. ( Lone, U; Madden, CJ; Stocker, SD; Sved, AF; Wilson, ME, 2006) |
| "Diazoxide is a non-diuretic benzothiadiazine derivative, one of a group of substances introduced into clinical practice in the 1950s for the treatment of hypertension." | 1.43 | Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. ( Inoue, Y; Komatsu, Y; Miyoshi, H; Nakamura, A; Tajima, K; Takano, T; Takihata, M; Terauchi, Y; Tsuchiya, H; Yahagi, S; Yamakawa, T; Yoshida, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsu, Y | 1 |
| Nakamura, A | 1 |
| Takihata, M | 1 |
| Inoue, Y | 1 |
| Yahagi, S | 1 |
| Tajima, K | 1 |
| Tsuchiya, H | 1 |
| Takano, T | 1 |
| Yamakawa, T | 1 |
| Yoshida, M | 1 |
| Miyoshi, H | 1 |
| Terauchi, Y | 1 |
| Stocker, SD | 1 |
| Wilson, ME | 1 |
| Madden, CJ | 1 |
| Lone, U | 1 |
| Sved, AF | 1 |
| Pennisi, AJ | 1 |
| Takahashi, M | 1 |
| Bernstein, BH | 1 |
| Singsen, BH | 1 |
| Uittenbogaart, C | 1 |
| Ettenger, RB | 1 |
| Malekzadeh, MH | 1 |
| Hanson, V | 1 |
| Fine, RN | 1 |
1 trial available for diazoxide and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Minoxidil therapy in children with severe hypertension.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Diazoxide; Drug Administration Schedu | 1977 |
2 other studies available for diazoxide and Water-Electrolyte Imbalance
| Article | Year |
|---|---|
Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Diazoxide; Drug Monitoring; Drug Resistance; Edema | 2016 |
Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretion stimulated by hemorrhage and hypotension but not hyperosmolality in rats.
Topics: Animals; Diazoxide; Dopamine beta-Hydroxylase; Hemorrhage; Hypotension; Hypothalamus; Injections, In | 2006 |